动脉硬性封闭性疾病的最新进展和前景
Hani Raka Karrar1,2, Mahmoud Ismail Nouh1,3, Amnah Alhassan Alnami4
1Department of Pharmaceutical, Dr. Samir Abbas Hospital, Jeddah, Saudi Arabia.
Annals of African medicine
|February 16, 2025
概括
动脉样硬化是导致死亡的主要原因,它涉及动脉中斑块的积累. 管理侧重于生活方式的改变,医疗护理,并越来越多,内血管治疗,以获得更好的结果.
科学领域:
- 心血管医学 心血管医学
- 血管生物学 血管生物学
背景情况:
- 动脉样硬化是全球死亡和残疾的主要原因,特别是在发达国家.
- 脑卒中和心脏病发作等急性血管事件通常是动脉样板破裂的结果.
研究的目的:
- 为了提供对动脉样硬化的全面概述.
- 讨论风险因素,流行病学,诊断方法和管理策略.
主要方法:
- 审查有关动脉样硬化的现有文献.
- 分析诊断方法,包括血液检查,心脏图和压力测试.
- 检查管理策略,包括改变生活方式,医疗护理和内血管治疗.
主要成果:
- 动脉样硬化斑块的进展涉及脂质积累,光滑肌肉细胞的增殖和血管生成.
- 自20世纪中叶以来,缺血性心脏病和中风的发病率和死亡率在高收入国家下降.
- 与传统手术相比,内血管治疗提供了一种侵入性较小的选择,患病率和死亡率较低.
结论:
- 动脉样硬化需要一个多方面的管理方法.
- 改变生活方式和医疗干预仍然至关重要.
- 内血管治疗在治疗动脉样硬化疾病方面呈现出有前途的进展.
相关概念视频
Ischemic Heart Disease: Overview
1.1K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.1K
Overview of Systemic Arteries
758
The human body is a complex, well-organized machine, and at the heart of its operations lies the circulatory system. This network of blood vessels, which includes systemic arteries, plays a vital role in maintaining life by transporting nutrients, oxygen, and waste products to and from cells throughout the body.
Systemic circulation is the part of the cardiovascular system that carries oxygenated blood away from the heart to the body's tissues and returns deoxygenated blood back to the...
Systemic circulation is the part of the cardiovascular system that carries oxygenated blood away from the heart to the body's tissues and returns deoxygenated blood back to the...
758
Pulmonary Hypertension: Classification and Pathogenesis
147
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
147
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
COPD: Pathogenesis and Clinical Features
226
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
226
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
145
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
145


